Severe Hypertriglyceridemia in Argentina: Prevalence and Clinical Characteristics

pp. 140-143

Authors

  • Benjamin Sáenz Universidad FASTA, Facultad de Medicina, Cátedra de Farmacología Especial y Toxicología, Mar del Plata. https://orcid.org/0000-0002-7926-0715
  • María G. Matta Universidad FASTA, Facultad de Medicina, Cátedra de Farmacología Especial y Toxicología, Mar del Plata.
  • Facundo Blautzik Universidad FASTA, School of Medicine, Chair of Special Pharmacology and Toxicology, Mar del Plata
  • Agustina Corral Universidad FASTA, School of Medicine, Chair of Special Pharmacology and Toxicology, Mar del Plata
  • Facundo Sampayo HIGA Dr. Oscar Alende, Internal Medicine Residency, Mar del Plata
  • Federico Piedrabuena HIGA Dr. Oscar Alende, Internal Medicine Residency, Mar del Plata
  • Pablo Corral 1 Universidad FASTA, School of Medicine, Chair of Special Pharmacology and Toxicology, Mar del Plata. https://orcid.org/0000-0003-0017-8725

DOI:

https://doi.org/10.7775/rac.es.v91.i2.20610

Keywords:

Hypertriglyceridemia, Triglycerides, Prevalence, Argentina

Abstract

Background: Severe hypertriglyceridemia (SHTG) is a metabolic disorder with multiple origins and management implications.
Prevalence, clinical characteristics, and its possible causes are unknown in Argentina.
Objective: The aim of this study was to estimate the prevalence and describe the clinical characteristics and underlying SHTG
causes in a third level hospital in the municipality of General Pueyrredón.
Methods: An observational, descriptive study was performed using an electronic database from a provincial Hospital. It included
adult patients with triglyceride (TG) levels above 885 mg/dL (10 mmol/L) evaluated from January 2018 to December 2021. Medical
records were collected, and patients were then contacted to obtain anthropometric measurements, sociodemographic variables,
personal and family history, secondary causes of hypertriglyceridemia, and treatment received.
Results: Among 16 029 patients analyzed, 46 presented SHTG, representing a total prevalence of 0.28% (95% CI 0.20-0.40%). Finally,
19 participants with mean age 48.47±16 years and 84.2% men were included in the analysis. Median TG level was 1821 mg/dL (interquartile range 917-7000 mg/dL), and 17 participants (84.97%) had hypercholesterolemia (total cholesterol >200 mg/dL). Almost 50% reported alcohol consumption, 55% were obese and 68% had type II diabetes. Nine participants were under pharmacological treatment, 4 with fibrates and 5 with statins.
Conclusion: A prevalence of 0.28% SHTG was found, higher than that reported in other series. Another finding was the underuse of
medication for this severe dyslipidemia.

How to cite this article:

Sáenz B, Matta M, Blautzik F, Corral A, Sampayo F, Piedrabuena F, et al.Severe Hypertriglyceridemia in Argentina: Prevalence and Clinical Characteristics. Rev Argent Cardiol 2023;91:140-3
https://doi.org/10.7775/rac.v91.i2

 

Published

2023-05-15

Issue

Section

BRIEF ARTICLES